Horizon Technology Finance Corporation (HRZN) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Horizon Technology Finance Corporation (HRZN) Financial Services Profile

Horizon Technology Finance Corporation is a specialty finance company providing secured debt and venture loans to development-stage companies in technology, life science, healthcare, and cleantech. As a business development company (BDC), HRZN focuses on generating current income and capital appreciation through investments in innovative, high-growth businesses within the United States.

What Is the Investment Thesis for HRZN?

Horizon Technology Finance Corporation presents a compelling investment case based on its specialization in venture debt financing for high-growth technology and life science companies. The company's focus on secured debt investments provides a degree of downside protection, while warrant and equity positions offer potential for capital appreciation. With a dividend yield of 26.87%, HRZN provides substantial income to investors. Key catalysts include the continued demand for venture debt among innovative companies and Horizon's ability to maintain a high-quality loan portfolio. However, investors should be aware of risks such as interest rate sensitivity and potential credit losses in a volatile economic environment. Monitoring the company's net interest margin and asset quality is crucial for assessing its long-term sustainability.

Based on FMP financials and quantitative analysis

HRZN Key Highlights

Market capitalization of $254M indicates a relatively small but established player in the BDC space.

• A P/E ratio of 9.5 suggests the company may be undervalued compared to its earnings.
• Profit margin of 37.5% demonstrates strong profitability in its lending operations.
• Gross margin of 60.3% highlights efficient management of its investment portfolio.
• Dividend yield of 26.87% provides a significant income stream for investors, reflecting its BDC structure.

Who Are HRZN's Competitors?

HRZN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HRZN's Key Strengths?

High dividend yield provides attractive income for investors.

• Specialization in high-growth technology and life science sectors.
• Secured debt investments offer downside protection.
• Experienced management team with strong industry relationships.

What Are HRZN's Weaknesses?

Sensitivity to interest rate fluctuations.

• Potential for credit losses in a volatile economic environment.
• Reliance on venture capital funding for portfolio companies.
• Smaller market capitalization compared to larger BDCs.

What Could Drive HRZN Stock Higher?

HRZN catalyst: Potential interest rate cuts by the Federal Reserve could reduce borrowing costs and improve net interest margin.

• Continued demand for venture debt financing among technology and life science companies.
• Expansion of the company's investment portfolio into new geographic markets.

What Are the Key Risks for HRZN?

Financial-distress signal — its Altman Z-Score of 0.19 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.
• Economic downturn impacting the ability of portfolio companies to repay loans.
• Sensitivity to interest rate fluctuations affecting net interest margin.
• Increased competition from other BDCs and specialty finance companies.

What Are the Growth Opportunities for HRZN?

• Expansion into New Geographies: Horizon can expand its lending operations into new geographic markets within the United States, targeting regions with emerging technology and life science hubs. This geographic diversification can reduce concentration risk and tap into new sources of deal flow. The market for venture debt in underserved regions represents a significant growth opportunity, potentially adding $50-100 million in new loan originations over the next 3-5 years.
• Increased Investment in Healthcare Information and Services: With the growing demand for digital health solutions and healthcare IT infrastructure, Horizon can increase its investments in healthcare information and services companies. This sector offers attractive growth prospects due to the ongoing digital transformation of the healthcare industry.
• Strategic Partnerships with Venture Capital Firms: Horizon can form strategic partnerships with leading venture capital firms to gain access to a pipeline of high-quality investment opportunities. By collaborating with VC firms, Horizon can identify promising early-stage companies and secure attractive lending deals. These partnerships can enhance Horizon's deal sourcing capabilities and improve the overall quality of its investment portfolio.
• Development of New Financing Products: Horizon can develop new financing products tailored to the specific needs of its target companies. This could include revenue-based financing, equipment financing, or other specialized lending solutions. By offering a broader range of financing options, Horizon can attract a wider range of borrowers and increase its market share. The demand for customized financing solutions is growing, presenting a significant opportunity for Horizon to innovate and differentiate itself.
• Leveraging Technology for Enhanced Efficiency: Horizon can leverage technology to streamline its operations, improve its underwriting process, and enhance its portfolio monitoring capabilities. By investing in advanced data analytics and automation tools, Horizon can reduce costs, improve decision-making, and enhance its overall efficiency. The adoption of fintech solutions can provide a competitive edge and drive long-term growth.

What Are HRZN's Competitive Advantages?

• Specialization in venture debt financing for high-growth sectors.
• Strong relationships with venture capital firms.
• Experienced management team with expertise in technology and life science lending.
• Disciplined underwriting process and risk management framework.

What Does HRZN Do?

Horizon Technology Finance Corporation is a business development company (BDC) that focuses on lending to and investing in development-stage companies. Founded to address the financing gap for venture capital-backed businesses, Horizon specializes in providing secured debt and venture lending to companies in the technology, life science, healthcare information and services, and cleantech industries. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments and capital appreciation from warrant and equity positions. Horizon operates primarily in the United States, targeting companies that have strong venture capital backing and are poised for rapid growth. The company's financing solutions help these businesses fund their growth initiatives, expand their operations, and bring innovative products and services to market. Horizon's approach involves a rigorous due diligence process and ongoing monitoring of its portfolio companies to manage risk and ensure strong investment performance. As a BDC, Horizon is regulated under the Investment Company Act of 1940 and is required to distribute a significant portion of its income to shareholders, making it a noteworthy option for income-seeking investors.

What Products and Services Does HRZN Offer?

• Provide secured debt financing to venture capital-backed companies.
• Offer venture lending solutions to development-stage businesses.
• Invest in technology, life science, healthcare, and cleantech industries.
• Generate current income through debt investments.
• Seek capital appreciation from warrant and equity positions.
• Operate as a business development company (BDC).
• Distribute a significant portion of income to shareholders.

How Does HRZN Make Money?

• Originate and structure secured debt and venture loans to venture capital-backed companies.
• Generate revenue through interest income on loans and capital gains on warrant and equity positions.
• Manage a portfolio of investments in high-growth sectors.
• Distribute a significant portion of taxable income to shareholders to maintain BDC status.

What Industry Does HRZN Operate In?

Horizon Technology Finance Corporation operates within the asset management industry, specifically focusing on venture debt financing. The market for venture debt has grown as venture capital-backed companies seek non-dilutive financing options to fund their growth. The competitive landscape includes other BDCs and specialty finance companies that offer similar lending services. Horizon differentiates itself through its focus on specific high-growth sectors such as technology, life science, and cleantech. The industry is influenced by macroeconomic factors, interest rate trends, and the overall health of the venture capital ecosystem.

Who Are HRZN's Key Customers?

• Venture capital-backed companies in the technology sector.
• Life science companies requiring growth capital.
• Healthcare information and services businesses.
• Cleantech companies developing sustainable solutions.

Over the past six months, Horizon Technology Finance Corporation insiders filed 10 SEC Form 4 transactions — 0 sales and 10 purchases. On net that is roughly 295K shares acquired (about $656K) — insiders putting money in tends to read as conviction.

Wall Street analysts project Horizon Technology Finance Corporation revenue of about $105.5M for fiscal 2026, with EPS near $0.67.

Horizon Technology Finance Corporation has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 10.7% below estimates on average.

Horizon Technology Finance Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 0.19 places it in the distress zone, a signal of elevated financial risk.

Return on equity for Horizon Technology Finance Corporation stands at 6.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.7%, showing how much profit it generates from its asset base. HRZN trades at a trailing price-to-earnings ratio of 9.46, below the Financial Services sector average of ~18x. Its free cash flow yield is 62.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.34 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 10.6%, the inverse of the P/E and a quick read on earnings relative to price.

Horizon Technology Finance Corporation (HRZN) Valuation Context

Valued at $254M, HRZN is classified as a micro-cap stock. Relative to its peer group, HRZN's quantitative score of 65/100 is roughly in line with the peer average of 69/100.

HRZN Revenue & Earnings Trend

In Q2 2026, HRZN generated $18.9M in top-line revenue, marking a sequential decrease of 20.9%. The company recorded a net loss of $37.3M, with diluted EPS of $-0.57. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Financial Services. Across the four most recent quarters, HRZN averaged $0.09 in diluted EPS.

Company Profile

Horizon Technology Finance Corporation operates in the Asset Management industry within the Financial Services sector. It is headquartered in Farmington, US. The company is led by CEO Michael Phillip Balkin. HRZN has traded publicly since 2010.

HRZN Financials

HRZN Latest News

HRZN Analyst Consensus

HRZN MoonshotScore

HRZN Financial Services Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources